BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18406992)

  • 1. Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly.
    Jacobs LG
    Cardiol Clin; 2008 May; 26(2):157-67, v. PubMed ID: 18406992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly.
    Jacobs LG
    Clin Geriatr Med; 2006 Feb; 22(1):17-32, vii-viii. PubMed ID: 16377465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin therapy: evolving strategies in anticoagulation.
    Horton JD; Bushwick BM
    Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of coagulopathy in warfarin associated cerebral hemorrhage.
    Aiyagari V; Testai FD
    Curr Opin Crit Care; 2009 Apr; 15(2):87-92. PubMed ID: 19300085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivitamin supplements may affect warfarin anticoagulation in susceptible patients.
    Kurnik D; Lubetsky A; Loebstein R; Almog S; Halkin H
    Ann Pharmacother; 2003 Nov; 37(11):1603-6. PubMed ID: 14565795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prothrombin complex concentrate good in warfarin induced hemorrhage. Quick reversal--plasma should be avoided].
    Själander A; Berntorp E; Svensson PJ
    Lakartidningen; 2009 Sep 9-15; 106(37):2278, 2280-1. PubMed ID: 19817161
    [No Abstract]   [Full Text] [Related]  

  • 7. Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
    Tay KH; Lip GY; Lane DA
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):392-3. PubMed ID: 19542940
    [No Abstract]   [Full Text] [Related]  

  • 8. Warfarin prevalence, indications for use and haemorrhagic events.
    Ouirke W; Cahill M; Perera K; Sargent J; Conway J
    Ir Med J; 2007 Mar; 100(3):402-4. PubMed ID: 17491542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K and thrombosis.
    Merli GJ; Fink J
    Vitam Horm; 2008; 78():265-79. PubMed ID: 18374199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemorrhagic complications during warfarin treatment].
    Gumulec J; Kessler P; Penka M; Klodová D; Králová S; Brejcha M; Wróbel M; Sumná E; Blatný J; Klaricová K; Riedlová P; Lasota Z
    Vnitr Lek; 2006 Mar; 52 Suppl 1():79-91. PubMed ID: 16637455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rivaroxaban: mode of action].
    Drouet L
    Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S9-15. PubMed ID: 19185786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of excessive anticoagulation or bleeding.
    Makris M
    Semin Vasc Med; 2003 Aug; 3(3):279-84. PubMed ID: 15199461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What to do when warfarin therapy goes too far.
    Prasad S; Wootten MR; Kulinski N; Chapman SA
    J Fam Pract; 2009 Jul; 58(7):346-52. PubMed ID: 19607771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K intake and sensitivity to warfarin in patients consuming regular diets.
    Lubetsky A; Dekel-Stern E; Chetrit A; Lubin F; Halkin H
    Thromb Haemost; 1999 Mar; 81(3):396-9. PubMed ID: 10102468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial comparing 1 mg of oral vitamin K with no treatment in the management of warfarin-associated coagulopathy in patients with mechanical heart valves.
    Ageno W; Garcia D; Silingardi M; Galli M; Crowther M
    J Am Coll Cardiol; 2005 Aug; 46(4):732-3. PubMed ID: 16098445
    [No Abstract]   [Full Text] [Related]  

  • 16. Current challenges of anticoagulant treatment.
    Ginghină C; Giuşcă S; Serban M; Popescu BA; Jurcuţ R; Uscăţescu V
    Rom J Intern Med; 2007; 45(3):221-7. PubMed ID: 18333353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 18. Warfarin-induced bleeding complications - clinical presentation and therapeutic options.
    Wiedermann CJ; Stockner I
    Thromb Res; 2008; 122 Suppl 2():S13-8. PubMed ID: 18549907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical management of coagulopathy associated with warfarin.
    Garcia D; Crowther MA; Ageno W
    BMJ; 2010 Apr; 340():c1813. PubMed ID: 20404060
    [No Abstract]   [Full Text] [Related]  

  • 20. Practical application of the 10-mg warfarin initiation nomogram.
    Wells PS; Le Gal G; Tierney S; Carrier M
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):403-8. PubMed ID: 19521238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.